McNeil Product Reclassification Accounts For 50% International Sales Gain
This article was originally published in The Tan Sheet
Executive Summary
McNeil's international OTC drug and nutritional sales rose 50% on a reported basis in the second quarter, reflecting the addition of a number of OTCs that were previously part of parent J&J's pharmaceutical group